Cargando…
Acute cerebellar ataxia during acute COVID-19: A case series and review of the literature
Acute coronavirus disease 2019 (COVID-19)-associated cerebellar ataxia without multisystem inflammatory syndrome in children (MIS-C) or encephalopathy in children has been rarely reported. We reviewed medical records of hospitalized children who had developed cerebellar ataxia during the acute phase...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101482/ https://www.ncbi.nlm.nih.gov/pubmed/37061090 http://dx.doi.org/10.1016/j.jiac.2023.04.003 |
_version_ | 1785025527262740480 |
---|---|
author | Takao, Hiroyuki Iijima, Hiroyuki Odagiri, Rika Hayakawa, Itaru Ogimi, Chikara |
author_facet | Takao, Hiroyuki Iijima, Hiroyuki Odagiri, Rika Hayakawa, Itaru Ogimi, Chikara |
author_sort | Takao, Hiroyuki |
collection | PubMed |
description | Acute coronavirus disease 2019 (COVID-19)-associated cerebellar ataxia without multisystem inflammatory syndrome in children (MIS-C) or encephalopathy in children has been rarely reported. We reviewed medical records of hospitalized children who had developed cerebellar ataxia during the acute phase of COVID-19 infection, without MIS-C or encephalopathy, in our center. We also conducted a literature review and summarized the clinical characteristics, treatment, and outcomes. We found three cases in our center and additional three cases in the literature. All patients were male and five were preschool children. The cerebellar symptoms started between day 2 and day 10 during the acute phase of the COVID-19 infection. Two cases were complicated by mutism. One patient received therapy for acute cerebellar ataxia with corticosteroids, and others did not receive any specific therapy for acute cerebellar ataxia. The symptoms improved completely in all patients, with the recovery interval ranging from one week to two months. Further studies are warranted to elucidate the pathogenesis of acute cerebellar ataxia during acute COVID-19 in children. |
format | Online Article Text |
id | pubmed-10101482 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101014822023-04-14 Acute cerebellar ataxia during acute COVID-19: A case series and review of the literature Takao, Hiroyuki Iijima, Hiroyuki Odagiri, Rika Hayakawa, Itaru Ogimi, Chikara J Infect Chemother Case Report Acute coronavirus disease 2019 (COVID-19)-associated cerebellar ataxia without multisystem inflammatory syndrome in children (MIS-C) or encephalopathy in children has been rarely reported. We reviewed medical records of hospitalized children who had developed cerebellar ataxia during the acute phase of COVID-19 infection, without MIS-C or encephalopathy, in our center. We also conducted a literature review and summarized the clinical characteristics, treatment, and outcomes. We found three cases in our center and additional three cases in the literature. All patients were male and five were preschool children. The cerebellar symptoms started between day 2 and day 10 during the acute phase of the COVID-19 infection. Two cases were complicated by mutism. One patient received therapy for acute cerebellar ataxia with corticosteroids, and others did not receive any specific therapy for acute cerebellar ataxia. The symptoms improved completely in all patients, with the recovery interval ranging from one week to two months. Further studies are warranted to elucidate the pathogenesis of acute cerebellar ataxia during acute COVID-19 in children. Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. 2023-08 2023-04-13 /pmc/articles/PMC10101482/ /pubmed/37061090 http://dx.doi.org/10.1016/j.jiac.2023.04.003 Text en © 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Case Report Takao, Hiroyuki Iijima, Hiroyuki Odagiri, Rika Hayakawa, Itaru Ogimi, Chikara Acute cerebellar ataxia during acute COVID-19: A case series and review of the literature |
title | Acute cerebellar ataxia during acute COVID-19: A case series and review of the literature |
title_full | Acute cerebellar ataxia during acute COVID-19: A case series and review of the literature |
title_fullStr | Acute cerebellar ataxia during acute COVID-19: A case series and review of the literature |
title_full_unstemmed | Acute cerebellar ataxia during acute COVID-19: A case series and review of the literature |
title_short | Acute cerebellar ataxia during acute COVID-19: A case series and review of the literature |
title_sort | acute cerebellar ataxia during acute covid-19: a case series and review of the literature |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101482/ https://www.ncbi.nlm.nih.gov/pubmed/37061090 http://dx.doi.org/10.1016/j.jiac.2023.04.003 |
work_keys_str_mv | AT takaohiroyuki acutecerebellarataxiaduringacutecovid19acaseseriesandreviewoftheliterature AT iijimahiroyuki acutecerebellarataxiaduringacutecovid19acaseseriesandreviewoftheliterature AT odagiririka acutecerebellarataxiaduringacutecovid19acaseseriesandreviewoftheliterature AT hayakawaitaru acutecerebellarataxiaduringacutecovid19acaseseriesandreviewoftheliterature AT ogimichikara acutecerebellarataxiaduringacutecovid19acaseseriesandreviewoftheliterature |